Call Us Today! 1.800.928.7496|info@ic-network.com

Industry News

//Industry News

Corporate, industry, pharmaceutical and medical device news announcements, press releases, developments and stories for the interstitial cystitis, bladder pain, pelvic pain communities, including: research studies, clinical trials, FDA approvals, recalls and safety alerts

Canada IC Guidelines Finally Adopted – Patients Get Much Needed Guidance

Why have so many interstitial cystitis patients in Canada come to the USA for care? Despite the glowing reviews about universal health care, there is a sad IC truth behind the scenes north of the border. There is no national IC organization to advocate on their behalf. Only a handful of physicians in the nation specialize in [...]

By |December 7th, 2016|Awareness, Diagnosis, ICN Announcements, Industry News, Interstitial Cystitis Network Blog, News, Research, Treatments|Comments Off on Canada IC Guidelines Finally Adopted – Patients Get Much Needed Guidance

Orphan Drug Status for Pentosan May Deter Lower Price Generics

Bene Arzneimittel GmBH, a german pharmaceutical company, announced in late December 2015 that Pentosan polysulphate (aka Elmiron) has been officially registered as an orphan drug for the treatment of interstitial cystitis by the European Medicines Agency, EMA. "Receiving orphan drug status for pentosan polysulphate in the European Union is a great success for bene", says [...]

By |January 8th, 2016|Industry News, Interstitial Cystitis Network Blog, News|Comments Off on Orphan Drug Status for Pentosan May Deter Lower Price Generics

Dr. Robert Echenberg, International Pelvic Pain Expert, Expands Clinic To NYC

Dr. Robert Echenberg, one of the top pelvic pain specialists in the world, has announced that he is expanding his practice to New York City effective December 1st, 2015. He will be seeing patients two days a week in NYC and one day a week in his clinic in Pennsylvania. Known for both his patient compassion [...]

By |November 24th, 2015|ICN Announcements, Industry News, Interstitial Cystitis Network Blog, News, Pelvic Pain|Comments Off on Dr. Robert Echenberg, International Pelvic Pain Expert, Expands Clinic To NYC

Take A Survey About Prelief

One of the oldest and most trusted OTC supplements used by patients who struggle with acid sensitivity is Prelief! Developed by Alan Kligerman and AKPharma, it has helped millions of people in the past 25 years enjoy a more balanced diet. Alan has retired and a new company, DSE Health Care Solutions, has purchased Prelief [...]

By |October 23rd, 2015|Industry News, Interstitial Cystitis Network Blog|Comments Off on Take A Survey About Prelief

Uk Approves Gepan For Home Use – A Chondroitin Bladder Instillation

Gepan instill, a potential treatment for cystitis and overactive bladder, has been added to the Drug Tariff effective October 1, 2015! This means that people with chronic cystitis and overactive bladder syndrome can now easily treat themselves in the comfort and convenience of their own homes rather than having to go to hospital clinics. This [...]

By |October 17th, 2015|Industry News, Interstitial Cystitis Network Blog, News|Comments Off on Uk Approves Gepan For Home Use – A Chondroitin Bladder Instillation

Introducing Hep-Lido-A Bladder Instillation For Interstitial Cystitis

The most popular and some would argue effective bladder instillation treatment on the market today for interstitial cystitis is heparin and lidocaine. Heparin acts as a soothing bladder coating while lidocaine numbs the nerves in the bladder wall. As a result, many patients walk out of their urologists office feeling dramatically better. Granted, it may [...]

By |April 28th, 2015|Industry News, Interstitial Cystitis Network Blog, News|Comments Off on Introducing Hep-Lido-A Bladder Instillation For Interstitial Cystitis

New IC Treatments Use Liposomes To Deliver BotoxA Into The Bladder

By Jill Heidi Osborne MA Very interesting Botox study crossed my desk today. As you probably know, BotoxA has been used for the treatment of various bladder conditions for several years now. Though it's not approved specifically for the treatment of interstitial cystitis, it is a STEP FOUR treatment option in the AUA's IC/BPS Treatment [...]

By |December 15th, 2014|Industry News, Interstitial Cystitis Network Blog, News, Research, Treatments|Comments Off on New IC Treatments Use Liposomes To Deliver BotoxA Into The Bladder

Interstitial Cystitis Treatment Guidelines Updated by AUA in Fall 2014

The American Urological Association (AUA) released a new update to their 2011 Guideline on the Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS). The original guidelines included research studies up through 2009. This new revision includes research studies through 2013. Read the amended guidelines here! “Although the science relevant to IC/BPS is continually improving [...]

By |October 21st, 2014|Industry News, Interstitial Cystitis IC/BPS, Interstitial Cystitis Network Blog, News, Pelvic Floor Dysfunction|Comments Off on Interstitial Cystitis Treatment Guidelines Updated by AUA in Fall 2014

Great New IC Book Released – The Proactive Patient: Managing IC/BPS and Related Conditions by Gaye and Andrew Sandler

Gaye & Andrew Sandler have released their first new book in a decade for men, women & children struggling with IC and its many related conditions. What sets this husband and wife team apart from so many other authors who have written about interstitial cystitis is their focus on patient comfort. In The Proactive Patient: Managing [...]

By |August 4th, 2014|Awareness, ICN Shop & Mail Order Center, Industry News, Interstitial Cystitis IC/BPS, Interstitial Cystitis Network Blog, Jill's Journal, News, Pelvic Floor Dysfunction, Self-Help Tips for IC, Bladder & Pelvic Pain|Comments Off on Great New IC Book Released – The Proactive Patient: Managing IC/BPS and Related Conditions by Gaye and Andrew Sandler

New Bladder Pain Treatment In Development – IC Clinical Trial

The Interstitial Cystitis Network is pleased to inform you that a research study is now enrolling women between the ages of 18 and 75 who have IC/BPS. This study will assess the effectiveness of an oral investigational study medicine (AQX-1125) to see if it will reduce the moderate to severe IC/BPS pain being experienced by [...]

By |July 22nd, 2014|Clinical Trials, Industry News, Interstitial Cystitis Network Blog, Research|Comments Off on New Bladder Pain Treatment In Development – IC Clinical Trial